Monies Held in Trust. Subject to Section 6.4, the Equityholder shall hold all monies received by it that constitute Issuer Pledged Collateral (including any payment or other benefit in breach of this Section 6.10 or Section 6.11) in trust for the Trustee for the benefit of the Noteholders.
Appears in 2 contracts
Samples: Pledge and Security Agreement (Theravance Biopharma, Inc.), Pledge and Security Agreement (Theravance Biopharma, Inc.)
Monies Held in Trust. Subject to Section 2.1(c) and Section 6.4, the each Equityholder shall hold all monies received by it that constitute Issuer Pledged Collateral of such Equityholder (including any payment or other benefit in breach of this Section 6.10 or Section 6.11) in trust for the Trustee for the benefit of the NoteholdersTrustee.
Appears in 2 contracts
Samples: Pledge and Security Agreement (Biocryst Pharmaceuticals Inc), Pledge and Security Agreement (PDL Biopharma, Inc.)
Monies Held in Trust. Subject to Section 2.1(c) and Section 6.4, the each Equityholder shall hold all monies received by it that constitute Issuer Pledged Collateral of such Equityholder (including any payment or other benefit in breach of this Section 6.10 6.11 or Section 6.116.12) in trust for the Trustee for Trustee, in order to satisfy the benefit Secured Obligations pursuant to the direction of the NoteholdersTrustee.
Appears in 1 contract
Samples: Pledge and Security Agreement (Indevus Pharmaceuticals Inc)
